Edwards Larry Todd 4
4 · Arcutis Biotherapeutics, Inc. · Filed May 20, 2025
Insider Transaction Report
Form 4
Edwards Larry Todd
See Remarks
Transactions
- Sale
Common Stock
2025-05-19$14.07/sh−7,451$104,850→ 183,104 total
Footnotes (2)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") granted on February 22, 2024.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.6763 to $14.49, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.